A prolonged standoff in the Strait of Hormuz risks disrupting the supply of half of all US generic drugs, which are manufactured in India and rely on the waterway. Limited prescription stockpiles heighten the threat of shortages and inflation in pharmaceuticals.
- Half of US generic drugs are manufactured in India
- These drugs transit the Strait of Hormuz
- Prescription stockpiles are limited
- Supply chain disruptions could lead to shortages
- Geopolitical instability may increase medical supply chain volatility
- Financial market indicators like ^VIX and SPY may reflect heightened risk
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.